Conference abstract
Screening and prevention of cervical cancer in Dschang Health District: a glance on the first 3 years´ achievement of the “3T project”
Pan African Medical Journal - Conference Proceedings. 2023:18(105).03
Oct 2023.
doi: 10.11604/pamj-cp.2023.18.105.2212
Archived on: 03 Oct 2023
Contact the corresponding author
Keywords: Cervical cancer screening, precancerous lesions treatment, Dschang, Cameroon
Oral presentation
Screening and prevention of cervical cancer in Dschang Health District: a glance on the first 3 years´ achievement of the “3T project”
Kenfack Bruno1,2,&, Tankeu Happi G1, Fouogue Tsuala J1,3, Noubom M1,2, Sormani J4, Datchoua Moukan AM2, Lemoupa S3, Vassilakos P5, Petignat P4
1Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Cameroon, 2Dschang District hospital, West Region, Cameroon, 3Bafoussam Regional hospital, Cameroon, 4Division of Gynecology, Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland, 5Geneva Foundation for Medical Education and Research, Geneva, Switzerland
&Corresponding author
Introduction: cervical cancer is the second gynaecological cancer among women globally, mostly occurring in low- and middle-income (LMIC) countries. However, if diagnosed early, cervical cancer is one of the most successfully treatable forms of cancer. The aim of the ”3T (test, triage and treat) project” in Dschang is to screen women using an HPV test and do triage for HPV positive to select eligible cases and treat.
Methods: this is a 5-years prospective cohort study, going on in Dschang Health District Cameroon, targeting women aged between 30 and 49 years old. Data presented concern the first 2623 women screened from September 2018 to August 2021. The SecuTrial platform was used to enter data. The analyses were done using descriptive methods. The main indicators were the prevalence of HPV infection, the prevalence of precancerous lesions, the treatment used, and side effects.
Results: of the 2623 women who were screened, 482 were HPV-positive (18.4%), with 45 (9.3%) HPV 16, 71 (14.7%) HPV18/45, and 397 (82.4%) other high-risk HPV. Triage done using visual inspection with acetic acid (VIA) was positive for 273/478 women (57%) who were subsequently treated. Thermal ablation was the main treatment method used: in 264 cases (96.7%), followed by Large Loop Excision of transformation Zone (LLETZ) in 9 cases (3.3%). The most common side effect of treatment was watery discharge (77.8%).
Conclusion: HPV infection is relatively common in the Dschang Health District. Screen-triage-and-treat strategy is feasible and treatment side effects are minor.
Screening and prevention of cervical cancer in Dschang Health District: a glance on the first 3 years´ achievement of the “3T project”
Kenfack Bruno1,2,&, Tankeu Happi G1, Fouogue Tsuala J1,3, Noubom M1,2, Sormani J4, Datchoua Moukan AM2, Lemoupa S3, Vassilakos P5, Petignat P4
1Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Cameroon, 2Dschang District hospital, West Region, Cameroon, 3Bafoussam Regional hospital, Cameroon, 4Division of Gynecology, Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland, 5Geneva Foundation for Medical Education and Research, Geneva, Switzerland
&Corresponding author
Introduction: cervical cancer is the second gynaecological cancer among women globally, mostly occurring in low- and middle-income (LMIC) countries. However, if diagnosed early, cervical cancer is one of the most successfully treatable forms of cancer. The aim of the ”3T (test, triage and treat) project” in Dschang is to screen women using an HPV test and do triage for HPV positive to select eligible cases and treat.
Methods: this is a 5-years prospective cohort study, going on in Dschang Health District Cameroon, targeting women aged between 30 and 49 years old. Data presented concern the first 2623 women screened from September 2018 to August 2021. The SecuTrial platform was used to enter data. The analyses were done using descriptive methods. The main indicators were the prevalence of HPV infection, the prevalence of precancerous lesions, the treatment used, and side effects.
Results: of the 2623 women who were screened, 482 were HPV-positive (18.4%), with 45 (9.3%) HPV 16, 71 (14.7%) HPV18/45, and 397 (82.4%) other high-risk HPV. Triage done using visual inspection with acetic acid (VIA) was positive for 273/478 women (57%) who were subsequently treated. Thermal ablation was the main treatment method used: in 264 cases (96.7%), followed by Large Loop Excision of transformation Zone (LLETZ) in 9 cases (3.3%). The most common side effect of treatment was watery discharge (77.8%).
Conclusion: HPV infection is relatively common in the Dschang Health District. Screen-triage-and-treat strategy is feasible and treatment side effects are minor.
